Key Highlights
● Nasdaq suspended Tian Ruixiang Holdings' shares from trading effective March 5, 2026 after they closed at $0.10 or less for ten consecutive trading days, engaging the exchange's low-priced stocks rule.
● The company said it was working with advisers to seek a stay or reinstatement of its listing, while acknowledging there was no guarantee of success.
● A delay to its Annual Report for the year ended October 31, 2025 was disclosed in March 2026, citing incomplete financial statements and a change of auditor after dismissing its previous one in August 2025.
● A share exchange for Ren Talents Inc., completed in November 2025, was later unwound under an April 2026 agreement, with more than 3.2 million escrowed Class A shares cancelled.
Tian Ruixiang Holdings (OTC:TIRXF) is now quoted over the counter under the code TIRXF rather than on Nasdaq, where it previously traded as TIRX. The company's own announcement dated March 4, 2026 set out the reason: the shares had closed at $0.10 or less for ten consecutive trading days to February 27, 2026, which engaged Nasdaq's low-priced stocks rule. Nasdaq suspended trading from the open on March 5, 2026 and said it would remove the securities through a formal delisting filing.
Business Overview
Tian Ruixiang is a Cayman Islands Holding Company that operates as an insurance broker in China, largely through variable interest entity arrangements, with headquarters in Beijing. Its annual report for the year ended October 31, 2024 describes property and casualty distribution alongside health and life products, with Revenue earned as commissions paid by insurers whose policies customers buy. The top five insurance partners accounted for 90.7% of fiscal 2024 revenue, a concentration that leaves the Business exposed to any single partner relationship changing.
Latest Verified Results
The most recent audited figures available are in the annual filing for the year ended October 31, 2024, filed in January 2025. Net revenues were $3,219,336, the net loss was $3,986,928, total Assets were $39,979,194 and total Equity was $33,890,130. Unaudited interim statements for the six months to April 30, 2025 showed net revenue of $2,823,312, against $178,345 a year earlier, and a net loss of $2,890,362. Total assets rose to $49,692,861, while cash fell to about $197,000, with short-term investments near $27.8 million.
On March 4, 2026 the company notified a delay to its annual report for the year ended October 31, 2025, citing incomplete financial statements and a change of auditor after dismissing its previous one in August 2025. It expected higher revenue than the roughly $3.22 million of the prior year, alongside substantially higher operating expenses. No fiscal 2025 annual report has been found in the sources checked, so those expected results remain unverified.
Corporate Activity Around the Delisting
Early 2026 brought a burst of corporate announcements. Shareholders approved a one-for-fifty share consolidation on February 17, 2026, which the company said would take effect the week of March 16. Whether that consolidation was ultimately completed could not be verified from primary filings reviewed.
One item is confirmed: a share exchange for Ren Talents Inc., completed in November 2025, was unwound under an agreement dated April 21, 2026, with 3,211,010 escrowed Class A shares cancelled. The company disclosed this in a filing dated April 28, 2026.
Risks
Reporting is the central uncertainty. Without a filed fiscal 2025 annual report, investors lack audited current figures for a company whose share price has collapsed. Indicative quotes have ranged widely across data providers, suggesting very thin, volatile trading, with no clear reason established for the moves. Other risks include the revenue concentration among a small number of insurance partners, the enforceability of variable interest entity structures under Chinese law, possible Chinese restrictions on overseas listings, and currency conversion limits.
Overdue Annual Report Remains the Key Gate
Readers should watch first for the overdue annual report for the year ended October 31, 2025, with audited revenue, loss and cash figures. Second, watch for confirmation of the shares' trading tier and share count following any completed share consolidation. Third, watch whether any outcome from the Nasdaq appeal process is disclosed. Until then, the six months to April 30, 2025 remain the latest reliable financial picture available.






Please wait processing your request...